Medical Management of Chronic Pancreatitis in Children

Publication Date: February 1, 2021
Last Updated: March 14, 2022

Recommendations

Nutrition and endocrine

1. Patients with CP are at risk for macro- and micronutrient deficiencies. Patients should be monitored for growth and pubertal delay, dietary intake, and fat-soluble vitamin deficiencies. Growth and intake should be reviewed at every clinic visit, a minimum of every 6 to 12 months. Fat-soluble vitamin laboratory analysis should occur every 12 to 18 months or as clinically indicated. (1B)
315340

CP = chronic pancreatitis; DM = diabetes mellitus; EPI = exocrine pancreatic insufficiency; GI = gastrointestinal, OGTT = oral glucose tolerance test; PERT = pancreatic enzyme replacement therapy; QOL = quality of life

Overview

Title

Medical Management of Chronic Pancreatitis in Children

Authoring Organization